Rollout Map
Sign Up
H.R. 5160 House Health

Stem Cell Therapeutic and Research Reauthorization Act of 2025

Introduced
Sep 4, 2025
Sponsor
Rep. Smith, Christopher H. (R-NJ-4)
View on Congress.gov

STAGE 2 OF 8 — COMMITTEE CONSIDERATION

Currently in the House. Last action: ordered to be reported (amended) by the yeas and nays: 48 - 0 on May 21, 2026.

  1. House Introduced in House Sep 4, 2025
  2. House Referred to the House Committee on Energy and Commerce. Sep 4, 2025
  3. House Referred to the Subcommittee on Health. Sep 4, 2025
  4. House Subcommittee Consideration and Mark-up Session Held May 13, 2026
  5. House Forwarded by Subcommittee to Full Committee by Voice Vote. May 13, 2026
  6. House Committee Consideration and Mark-up Session Held May 21, 2026
  7. House Ordered to be Reported (Amended) by the Yeas and Nays: 48 - 0. May 21, 2026

Cosponsors

21

Subjects

Biological and life sciencesBlood and blood diseasesCell biology and embryologyHealth programs administration and fundingOrgan and tissue donation and transplantation

Committees

  • Energy and Commerce Committee
    • Markup By , May 21, 2026
    • Referred To , Sep 4, 2025

Summary

No summary available.

Bill Text

Formatted Text PDF Formatted XML

Related Bills

Comments · 0

Loading comments...